Connor, Clark & Lunn Investment Management (CC&L)
MYOV

Connor, Clark & Lunn Investment Management (CC&L)’s Myovant Sciences Ltd. MYOV Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-84,086
Closed -$1.04M – 1283
2022
Q2 		$1.04M Sell
84,086
-56,237
-40% -$621K 0.01% 615
2022
Q1 		$1.87M Sell
140,323
-46,844
-25% -$628K 0.01% 516
2021
Q4 		$2.91M Sell
187,167
-24,949
-12% -$476K 0.01% 447
2021
Q3 		$4.76M Sell
212,116
-27,244
-11% -$598K 0.02% 349
2021
Q2 		$5.45M Buy
239,360
+13,410
+6% +$282K 0.03% 338
2021
Q1 		$4.65M Buy
225,950
+5,035
+2% +$115K 0.03% 373
2020
Q4 		$6.1M Sell
220,915
-16,411
-7% -$319K 0.04% 297
2020
Q3 		$3.33M Sell
237,326
-116,381
-33% -$2.16M 0.02% 377
2020
Q2 		$7.29M Buy
353,707
+24,457
+7% +$333K 0.05% 239
2020
Q1 		$2.49M Buy
329,250
+139,039
+73% +$1.56M 0.02% 379
2019
Q4 		$2.95M Buy
+190,211
New +$1.92M 0.02% 351

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s MYOV Position: Q3 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 84,086 shares — an estimated $1.04M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MYOV in Q4 2019 and held it in 11 quarters. The position peaked at $7.29M in Q2 2020. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 84,086 Myovant Sciences Ltd. shares in Q3 2022, an estimated $1.04M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 11 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Myovant Sciences Ltd. position peaked at $7.29M in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2022, filed 10 Nov 2022.